(Q46935010)
Statements
1 reference
Rosiglitazone reduces liver fat and insulin requirements and improves hepatic insulin sensitivity and glycemic control in patients with type 2 diabetes requiring high insulin doses (English)
1 reference
Hannele Yki-Järvinen
1 reference
Leena Juurinen
1 reference
Anna Kotronen
1 reference
Marit Granér
1 reference
23 October 2007
1 reference
93
1 reference
1
1 reference
118-124
1 reference
Identifiers
1 reference